White House Announces New Efforts To Shore Up Drug Supply Chain

By Jessica Karins / November 28, 2023 at 12:37 PM
President Joe Biden is launching new efforts to address supply chain issues affecting medical products, including giving HHS more authority to boost manufacturing through the Defense Production Act and investing $35 million in sterile drug production. HHS announced the new actions Monday (Nov. 27) as part of the first meeting of a new White House Council on Supply Chain Resilience. Biden plans to issue a presidential determination to broaden HHS’ authorities under Title III of the Defense Production Act (DPA)...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.